Abstract:N6‑methyladenosine (m6A) is the most prevalent and abundant type of internal post‑transcriptional RNA modification in eukaryotic cells. Multiple types of RNA, including mRNAs, rRNAs, tRNAs, long non‑coding RNAs and microRNAs, are involved in m6A methylation. The biological function of m6A modification is dynamically and reversibly mediated by methyltransferases (writers), demethylases (erasers) and m6A binding proteins (readers). The methyltransferase complex is responsible for the catalyzation of m6A modification and is typically made up of methyltransferase‑like (METTL)3, METTL14 and Wilms tumor 1‑associated protein. Erasers remove methylation by fat mass and obesity‑associated protein and ALKB homolog 5. Readers play a role through the recognition of m6A‑modified targeted RNA. The YT521‑B homology domain family, heterogeneous nuclear ribonucleoprotein and insulin‑like growth factor 2 mRNA‑binding protein serve as m6A readers. The m6A methylation on transcripts plays a pivotal role in the regulation of downstream molecular events and biological functions, such as RNA splicing, transport, stability and translatability at the post‑transcriptional level. The dysregulation of m6A modification is associated with cancer, drug resistance, virus replication and the pluripotency of embryonic stem cells. Recently, a number of studies have identified aberrant m6A methylation in cardiovascular diseases (CVDs), including cardiac hypertrophy, heart failure, arterial aneurysm, vascular calcification and pulmonary hypertension. The aim of the present review article was to summarize the recent research progress on the role of m6A modification in CVD and give a brief perspective on its prospective applications in CVD.

Emerging Role of M6a RNA Methylation in Nutritional Physiology and Metabolism

The emerging roles of N6-methyladenosine RNA methylation in human cancers

M6a-Binding Proteins: the Emerging Crucial Performers in Epigenetics

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Epigenetic regulation of adipose tissue expansion and adipogenesis by<i>N</i><SUP>6</SUP>-methyladenosine

The Roles of M6a RNA Modifiers in Human Cancer

The role of m6A modification in the biological functions and diseases

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

The Critical Roles of M6a Modification in Metabolic Abnormality and Cardiovascular Diseases

The role of m6A modification in physiology and disease

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

Emerging Roles of RNA Methylation in Gastrointestinal Cancers

The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance

Role of m6A RNA methylation in cardiovascular disease (Review)

The role of m6A RNA methylation in human cancer

The potential role of RNA N6-methyladenosine in Cancer progression

Regulatory roles of N6-methyladenosine (m 6 A) methylation in RNA processing and non-communicable diseases

Regulation of m6Am RNA modification and its implications in human diseases

Update on N6-methyladenosine methylation in obesity-related diseases

Regulatory Roles of N6-methyladenosine (m6a) Methylation in RNA Processing and Non-Communicable Diseases